Nele Adriaenssens

Summary

Affiliation: Vrije Universiteit Brussel
Country: Belgium

Publications

  1. pmc Scapula alata in early breast cancer patients enrolled in a randomized clinical trial of post-surgery short-course image-guided radiotherapy
    Nele Adriaenssens
    Breast Clinic, Oncologic Surgery, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
    World J Surg Oncol 10:86. 2012
  2. pmc Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial
    Hilde Van Parijs
    Department of Radiotherapy, UZ Brussel, Brussels, Belgium
    Radiat Oncol 7:80. 2012
  3. pmc Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy
    Harijati Versmessen
    Department of Radiation Oncology, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Brussels, Belgium
    BMC Cancer 12:495. 2012
  4. pmc Early contralateral shoulder-arm morbidity in breast cancer patients enrolled in a randomized trial of post-surgery radiation therapy
    Nele Adriaenssens
    Breast Clinic, Oncological Surgery, UZ Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
    Breast Cancer (Auckl) 6:79-93. 2012
  5. pmc Ultrasound elastography as an objective diagnostic measurement tool for lymphoedema of the treated breast in breast cancer patients following breast conserving surgery and radiotherapy
    Nele Adriaenssens
    Physical Therapy Department, Universitair Ziekenhuis Brussel, Belgium Physical Therapy Department, Vrije Universiteit Brussel, Belgium
    Radiol Oncol 46:284-95. 2012

Detail Information

Publications5

  1. pmc Scapula alata in early breast cancer patients enrolled in a randomized clinical trial of post-surgery short-course image-guided radiotherapy
    Nele Adriaenssens
    Breast Clinic, Oncologic Surgery, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
    World J Surg Oncol 10:86. 2012
    ..We evaluated the risk factors associated with SA and the relationship of SA with ipsilateral shoulder/arm morbidity in a series of patients enrolled in a trial of post-surgery radiotherapy (RT)...
  2. pmc Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial
    Hilde Van Parijs
    Department of Radiotherapy, UZ Brussel, Brussels, Belgium
    Radiat Oncol 7:80. 2012
    ..hypofractionated Tomotherapy (TT) for post-operative treatment of breast cancer. The purpose of the trial is to compare whether TT can reduce heart and pulmonary toxicity. We evaluate early toxicities...
  3. pmc Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy
    Harijati Versmessen
    Department of Radiation Oncology, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Brussels, Belgium
    BMC Cancer 12:495. 2012
    ..Tomotherapy uses an integrated computed tomography scanner to improve treatment accuracy, aiming to reduce the adverse effects of radiotherapy...
  4. pmc Early contralateral shoulder-arm morbidity in breast cancer patients enrolled in a randomized trial of post-surgery radiation therapy
    Nele Adriaenssens
    Breast Clinic, Oncological Surgery, UZ Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
    Breast Cancer (Auckl) 6:79-93. 2012
    ..Shoulder/arm morbidity is a common complication of breast cancer surgery and radiotherapy (RT), but little is known about acute contralateral morbidity...
  5. pmc Ultrasound elastography as an objective diagnostic measurement tool for lymphoedema of the treated breast in breast cancer patients following breast conserving surgery and radiotherapy
    Nele Adriaenssens
    Physical Therapy Department, Universitair Ziekenhuis Brussel, Belgium Physical Therapy Department, Vrije Universiteit Brussel, Belgium
    Radiol Oncol 46:284-95. 2012
    ..Further research with longer follow-up and more patients is necessary to confirm our findings...